You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Covid-19 vaccine roll-out expected in less than 3 months in UK: Report

A mass roll-out of a Covid-19 vaccine in Britain could be finished in as little as three months, the Times reported, citing government scientists

Topics
Coronavirus Vaccine | UK | Coronavirus

Reuters 

covid-19, vaccine, coronavirus

(Reuters) - A mass roll-out of a COVID-19 vaccine in Britain could be finished in as little as three months, the Times reported, citing government scientists.

Scientists working on the Oxford vaccine hope regulators approve it before the beginning of 2021, the newspaper said.

A full COVID-19 immunization programme, which would exclude children, could be quicker than experts predicted, the Times said, adding that health officials estimate that every adult could receive a dose of the vaccine within six months.

The European Medicines Agency (EMA) said on Thursday it has started reviewing data on AstraZeneca and Oxford University's potential COVID-19 vaccine, in real time, the first of such moves aimed at speeding up any approval process in the region for a vaccine.

The news of the European review also raises chances of the British vaccine, which is seen as leading the race for a successful vaccine against COVID-19, becoming the first to be approved in Europe for the disease caused by the novel which has killed more than a million people globally.

The Times report added that plans under consideration by government include allowing a much wider group of healthcare staff to administer the vaccine, setting up of drive-through vaccination centres and recruiting help of armed forces.

 

 

(Reporting by Sabahatjahan Contractor in Bengaluru; Additional reporting by Rebekah Mathew in Bengaluru; Editing by Diane Craft and Matthew Lewis)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, October 03 2020. 16:30 IST
RECOMMENDED FOR YOU